Cancer Family
Secondary Malignant Neoplasm
CI-CAN-00000346SMNExplore in graph →
4,270 active trials56 approved drugs532 evidence items
- NCIt
- C4968
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000346SMNExplore in graph →
Clinical trials
14,664 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,961)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00351195 | Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 2 | 39 | Rigshospitalet, DenmarkOTHER | 1 | Aug 26, 2008 | clinicaltrials |
| NCT00129844 | Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | completed | Phase 2 | 108 | Pharmacyclics LLC.INDUSTRY | 2 | Aug 20, 2008 | clinicaltrials |
| NCT00239200 |
| Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus |
| terminated |
| Phase 2 |
| 29 |
| University of Michigan Rogel Cancer CenterOTHER |
| 1 |
| Jul 30, 2008 |
| clinicaltrials |
| NCT00056693 | Treatment With SU11248 in Patients With Neuroendocrine Tumors | completed | Phase 2 | 107 | PfizerINDUSTRY | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00422786 | Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma | completed | Phase 2 | 10 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00697814 | Clomiphene in Males With Prolactinomas and Persistent Hypogonadism | completed | Phase 2 | 15 | Federal University of São PauloOTHER | 1 | Jun 16, 2008 | clinicaltrials |
| NCT00298688 | A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer | completed | Phase 2 | 56 | AstraZenecaINDUSTRY | 2 | Jun 12, 2008 | clinicaltrials |
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 38 | Dana-Farber Cancer InstituteOTHER | 0 | Jun 4, 2008 | clinicaltrials |
| NCT00139230 | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00440934 | A Study of Electromagnetic Waves in the Treatment of the Advanced Hepatocarcinoma(THBC002) | terminated | Phase 2 | 0 | Pasche, Boris, M.D.INDIV | 1 | May 6, 2008 | clinicaltrials |
| NCT00652613 | Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | unknown | Phase 2 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00095186 | Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00635323 | Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma | completed | Phase 2 | 73 | PfizerINDUSTRY | 4 | Apr 7, 2008 | clinicaltrials |
| NCT00461344 | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer | terminated | Phase 2 | 20 | SanofiINDUSTRY | 0 | Apr 3, 2008 | clinicaltrials |
| NCT00384124 | Topical Imiquimod for Bowen's Disease of the Head and Neck | unknown | Phase 2 / Phase 3 | 50 | Brooke Army Medical CenterFED | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00059735 | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma | completed | Phase 2 | 30 | Eisai Inc.INDUSTRY | 2 | Mar 5, 2008 | clinicaltrials |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00082082 | A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | completed | Phase 2 | — | SciClone PharmaceuticalsINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site | terminated | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00056173 | Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 43 | Aptose Biosciences Inc.INDUSTRY | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00417677 | A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma | terminated | Phase 1 / Phase 2 | 124 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00165217 | Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | completed | Phase 2 | 37 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00388063 | Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma | completed | Phase 2 | 55 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00464295 | Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)(HCC-CAP) | completed | Phase 2 | 15 | Aga Khan UniversityOTHER | 1 | Dec 14, 2007 | clinicaltrials |
| NCT00122876 | Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 25 | Light Sciences OncologyINDUSTRY | 3 | Dec 7, 2007 | clinicaltrials |
| NCT00131651 | ATN-161 in Advanced Renal Cell Cancer | terminated | Phase 2 | 36 | AttenuonINDUSTRY | 1 | Dec 6, 2007 | clinicaltrials |
| NCT00073112 | A Study of ABT-751 in Patients With Renal Cell Cancer | completed | Phase 2 | 60 | AbbottINDUSTRY | 2 | Nov 29, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00557713 | XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma | unknown | Phase 2 | 44 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socialsOTHER | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00352833 | Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma | completed | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | Oct 26, 2007 | clinicaltrials |
| NCT00534664 | Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma(TheraBionic) | completed | Phase 1 / Phase 2 | 40 | University of Sao PauloOTHER | 1 | Sep 26, 2007 | clinicaltrials |
| NCT00073125 | Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 103 | AbbottINDUSTRY | 2 | Aug 15, 2007 | clinicaltrials |
| NCT00116389 | Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | terminated | Phase 2 | 60 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | terminated | Phase 2 | 24 | Swedish Medical CenterOTHER | 1 | Apr 5, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00134186 | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | completed | Phase 2 | 43 | Pharmacyclics LLC.INDUSTRY | 1 | Mar 5, 2007 | clinicaltrials |
| NCT00191503 | Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma | completed | Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191750 | A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned | completed | Phase 2 | 80 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00162669 | Bevacizumab in Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00356161 | HAI Via Interventionally Implanted Port Catheter Systems | unknown | Phase 2 | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00339586 | First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene | unknown | Phase 2 | 40 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00290316 | Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver | unknown | Phase 2 | — | Central Texas Veterans Health Care SystemOTHER | 1 | Jun 7, 2006 | clinicaltrials |
| NCT00168922 | Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Apr 27, 2006 | clinicaltrials |
| NCT00300521 | Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 40 | Beijing Chao Yang HospitalOTHER | 1 | Mar 9, 2006 | clinicaltrials |
| NCT00073502 | Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer | completed | Phase 2 | 43 | OSI PharmaceuticalsINDUSTRY | 3 | Feb 22, 2006 | clinicaltrials |
| NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | unknown | Phase 2 / Phase 3 | 286 | Charite University, Berlin, GermanyOTHER | 1 | Feb 14, 2006 | clinicaltrials |
| NCT00226798 | Immunochemotherapy for Metastatic Renal Cell Carcinoma | unknown | Phase 2 | 45 | Rambam Health Care CampusOTHER | 1 | Jan 4, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Aug 26, 2008source: clinicaltrials